Ferrous Sulfate,Dried.

Ascorbic acid reduces ferric iron back to the ferrous state and holds it in a soluble chelate through the duodenum. Taken in the same dose, it raises the share of non-heme iron that crosses the enterocyte.

Vitamin C keeps iron soluble at duodenal pH and counters binding by phytate and polyphenols in the same meal. This is the standard reason iron salts are formulated alongside it.

Calcium taken at the same time lowers non-heme iron uptake at the intestinal transport step. Formulators separate the two doses by several hours rather than combining them.

Calcium carbonate both competes with iron for uptake and raises gastric pH, and ferrous salts need an acid stomach to stay soluble. Both effects push iron absorption the same direction.

Iron and zinc both move through DMT1 and compete when a large dose of each arrives together. Splitting them across the day keeps each one's uptake intact.

Copper is built into the ferroxidases hephaestin and ceruloplasmin, which load iron onto transferrin for transport. Without adequate copper, absorbed iron stays in storage rather than moving into circulation.

Iron supplies the heme and B12 supports the DNA synthesis that dividing red cell precursors need. Formulas carry both because the pathway moves only as fast as the scarcer one.

Folate feeds the thymidine synthesis step that lets marrow precursors divide while iron fills their hemoglobin. Long-standing practice puts iron, folate and B12 in one formula for this reason.

Vitamin A status influences how readily stored iron is released from ferritin and moved into circulation. Adequate vitamin A therefore lets a given iron intake register more fully in blood.

Riboflavin-derived flavins support the reductase activity that frees iron from ferritin for transport. Riboflavin status changes how efficiently supplemental iron is used.

Galloylated catechins bind non-heme iron in the gut lumen into complexes the enterocyte cannot take up. Taken in the same window, green tea extract lowers the iron a ferrous salt delivers.

Quercetin is a recognised iron chelator and binds ferrous iron in the lumen and in plasma. Co-dosing lowers iron uptake, so the two are better spaced apart.

Phytate is the largest binder of non-heme iron in plant meals, and phytase breaks it down before it reaches the duodenum. Adding phytase to the same meal frees iron the salt would otherwise lose.

Ferrous salts need a low gastric pH to dissolve and stay in the ferrous state. Added gastric acidity keeps more of the dose soluble when it reaches the absorption site.

Lysine forms a soluble complex with ferrous iron that resists precipitation at intestinal pH. Amino acid pairing is the same principle behind bisglycinate chelates.

Lactobacilli lower luminal pH and produce metabolites that keep iron in its more absorbable ferrous form. The effect is modest and depends on the strain used.

Glycine forms a stable bidentate chelate with ferrous iron, which is the chemistry behind iron bisglycinate. Chelated iron is less available to bind dietary phytate and polyphenol inhibitors in the lumen and enters by a partly different route from free ionic iron. Presented as free glycine alongside ferrous sulfate the chelate does not fully form, so this describes the chemistry rather than a formulation shortcut.

DMT1 in the duodenal brush border carries ferrous iron, and it also carries manganese, so the two minerals compete for the same transporter when given together. High iron intake reduces manganese uptake and the same is true in the other direction. Separating the two doses is the usual answer.

Divalent minerals given together in a single large dose compete for shared uptake capacity in the upper small intestine. Magnesium in a high-dose supplement can reduce iron uptake from the same serving, and magnesium salts also raise luminal pH, which works against iron solubility. Spacing the two by a few hours removes most of the issue.

Ferrous iron stays soluble in the acid environment of the stomach and precipitates as insoluble ferric hydroxide as pH rises. Bicarbonate and other alkalising agents raise gastric pH and drive that precipitation before the iron reaches the duodenal absorption site. This is the same reason antacids and acid-reducing medicines reduce iron uptake.

Galloyl groups in tannins bind ferric iron tightly and form insoluble complexes in the gut lumen, and this is one of the strongest dietary inhibitors of non-heme iron absorption. Tea, coffee and tannin-rich botanicals all carry the same chemistry. Taking iron away from tannin-containing drinks is standard practice.

Coffee and tea reduce non-heme iron absorption, but the responsible compounds are the chlorogenic acids and tannins rather than caffeine itself. A caffeine ingredient sourced from green coffee or tea extract carries those polyphenols along with it, while pure caffeine anhydrous does not. The distinction matters when reading a label.

Curcumin is a documented iron chelator, binding ferric iron through its beta-diketone moiety, and this chelating behaviour has been described both in the gut and systemically. Taken in the same serving as an iron salt it can reduce the iron available for uptake. Separating the doses avoids the overlap.

Polyphenols with adjacent hydroxyl groups coordinate iron, and resveratrol and its relatives are described as iron-binding in the chemistry literature. In the lumen this reduces the free ferrous fraction presented to the transporter. The effect is dose-dependent and applies at the same-serving level rather than across the day.

Proanthocyanidins are condensed tannins and share the iron-binding chemistry that makes tea a strong inhibitor of non-heme iron uptake. A concentrated grape seed extract taken with an iron salt binds a share of the mineral before absorption. This is the expected result of the chemistry, not a defect of either ingredient.

A viscous fibre gel physically slows the diffusion of dissolved minerals to the mucosal surface and can entrap divalent cations. Taken in the same serving as an iron salt it reduces the fraction absorbed at that meal. Spacing the fibre from the mineral is the ordinary handling instruction.

Pectin carries free carboxyl groups that bind divalent cations including iron, and the gel it forms slows mineral diffusion. Colonic fermentation later releases some of what was bound, though absorption in the colon is limited. The practical point is that the iron and the fibre should not share a serving.

Activated charcoal adsorbs a wide range of luminal compounds non-selectively and is routinely kept away from anything intended to be absorbed. An iron salt taken in the same serving is partly bound and carried through. Charcoal belongs in its own dosing window.

Cysteine-containing peptides released during meat digestion keep iron in the reduced ferrous state and form soluble complexes, which is a well-described part of the meat factor that raises non-heme iron uptake. Free cysteine shares that reducing thiol chemistry. Whether a cysteine supplement reproduces the peptide effect at typical doses has not been established.

Lactoferrin binds two ferric ions per molecule with very high affinity and is itself an iron delivery form with a receptor-mediated uptake route. Given alongside an ionic iron salt it can sequester luminal iron rather than adding to the free pool. It is better understood as an alternative iron carrier than as an absorption enhancer for ferrous sulfate.

Certain lactic acid bacteria carry phytase activity and lower luminal pH through lactate production, both of which reduce phytate binding of iron and improve its solubility. This is the basis of traditional fermentation of cereal and legume foods. Strain-level phytase capacity varies and is rarely stated on a product.

Fermentable fibre lowers colonic pH through short-chain fatty acid production, which keeps minerals more soluble and has been associated with increased mineral uptake in the large bowel. The effect is better characterised for calcium and magnesium than for iron. The mechanism is plausible for iron and the human data on it is thin.

Galactooligosaccharides are fermented to short-chain fatty acids that acidify the colonic lumen and increase mineral solubility there. Prebiotics have also been studied as a way to reduce the microbiota disturbance that unabsorbed iron can cause. The relationship is supported mechanistically more than it is by iron-specific human trials.

Ferrous iron is a catalyst of lipid peroxidation, and long-chain polyunsaturated fatty acids are the most oxidisable lipids in a formula. Co-locating an iron salt with a fish oil in the same softgel or powder accelerates rancidity of the oil. Physical separation or effective encapsulation is the formulation control.

Free ferrous iron promotes oxidative degradation of tocopherols in a finished product, so an unprotected iron salt shortens the shelf life of the vitamin E it sits next to. This is a stability interaction in the container rather than a physiological one. Encapsulated or lipid-coated iron is the usual answer.

Dihydrolipoic acid is a dithiol that both chelates transition metals and reduces ferric to ferrous iron. Taken with an iron salt it changes the redox state and the complexation of the mineral in the lumen. The direction of the net effect on absorption has not been established in people.

Thiols reduce ferric iron to the ferrous form, which is both the absorbable form and the form that drives Fenton chemistry with peroxide. Whether that reads as an enhancement or a pro-oxidant risk depends on dose and on what else is present. Spacing a large thiol dose from a high-dose iron product avoids having to decide.